Breaking News

Parexel, Partex Partner to Accelerate Drug Discovery and Development

Aims to further advance drug development efforts to understand the probability of clinical success of client assets.

Parexel, a CRO providing a full range of Phase I to IV clinical development services, and Partex, a digital pharma platform, entered a strategic alliance designed to leverage artificial intelligence (AI)-powered solutions to accelerate drug discovery and development for biopharmaceutical customers, and to de-risk portfolio assets. Parexel’s extensive global expertise across Phase I to IV clinical development combined with Partex’s big data and AI capabilities aims to further advan...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters